Project Grant 20256701744726

Award Date 8/1/25
Completion Date 7/31/28
Dollars Obligated $392K
Federal Grant Program
10.310
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $586,250 in funding to the University of Massachusetts Medical School to conduct research on the generation and regulation of TFH13 cells that drive pathogenic IgE in allergies. The overarching goal is to elucidate the cell-extrinsic and cell-intrinsic pathways that lead to the differentiation of TFH13 cells,...
The North Carolina Agricultural and Technical State University (NC A&T) received a $600,000 Project Grant award from the United States Department of Agriculture National Institute of Food and Agriculture under the 1890 Institution Capacity Building Grants program (CFDA #10.216). The grant aims to develop, expand, and enhance food allergy research, teaching, and outreach opportunities for students and educators. Specifically, NC A&T will create new courses on food allergy principles for...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research into the role of immunoglobulin E (IgE) and the sugar-binding protein galectin-3 in the activation of basophils, which play a key role in allergic reactions. The $162,728 award, granted to The Johns Hopkins University, aims to investigate the mechanisms by which galectin-3 can activate basophils independently of allergen...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $300,000 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Cellergy Pharma Inc. in Wilmington, Delaware. The goal of this 2-year project is to develop an innovative antibody drug that can efficiently and specifically kill IgE-producing B cells to achieve complete and durable suppression of allergy symptoms without significant side effects. The funded research will determine the...
This federal Project Grant award of $828,775, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to study the role of food sensitization in the development of cardiovascular disease. The primary awardee, the University of North Carolina at Chapel Hill, will comprehensively assess the relationship between food-specific IgE antibodies and cardiovascular disease mortality,...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,310 to Yale University to conduct research aimed at elucidating the cellular and molecular mechanisms governing immunoglobulin E (IgE) catabolism. The research project seeks to uncover the receptors and cell types responsible for IgE clearance, as well as investigate the impact of IgE glycosylation on...
This four-year, $649,942 project grant from the United States Department of Agriculture National Institute of Food and Agriculture (USDA NIFA) Agriculture and Food Research Initiative (AFRI) program (CFDA 10.310) supports research at Clemson University to develop reduced immunogenic wheat genotypes for human consumption. The research aims to remove immunogenic gluten proteins from wheat through conventional breeding and genome editing methods. Researchers will stack null mutations at wheat...
This Project Grant award, valued at $162,000.00 and provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research conducted by the Trustees of Indiana University (doing business as Indiana University Indianapolis) to investigate the roles of TGF-beta signaling in regulating T follicular helper (Tfh) cell differentiation and mast cell function, and how disruption of this pathway may...
This Project Grant award of $753,304, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports a research project to comprehensively define the molecular basis of the IgE antibody response to the alpha-gal allergen in alpha-gal syndrome (red meat allergy). The awardee, Vanderbilt University Medical Center, will develop a panel of naturally occurring human IgE monoclonal antibodies from...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $667,013 Project Grant to The University of Texas Southwestern Medical Center, doing business as Southwestern Medical School, for a 5-year period from March 1, 2025 to February 28, 2030. The grant supports the development and validation of deep learning models to accurately identify antibody-antigen interactions and binding epitopes on antigens...

This $392,000 Project Grant award from the U.S. Department of Agriculture (USDA) National Institute of Food and Agriculture (NIFA) under the Agriculture and Food Research Initiative (AFRI) program will support research by The University of Texas Southwestern Medical Center to investigate the use of Immunoglobulin E (IgE) glycosylation as a biomarker to replace the oral food challenge test for diagnosing food allergies. The project aims to 1) analytically validate an IgE glycan test, 2) establish IgE-glycosylation cut-off levels for allergic reactivity, and 3) clinically validate IgE-glycosylation as a biomarker in a population undergoing peanut oral immunotherapy or without peanut allergy. This research seeks to provide an alternative to the current oral food challenge test, which can be unreliable, by examining how post-translational modifications of IgE impact its anaphylactic potential and ability to predict allergic responses.

Generated 7/15/25, 8:15 AM